REINTGEN, D. S., PICKETT, N. J., LUCAS, V. S., HUANG, A. T., & SEIGLER, H. F. (1983). CLINICAL-TRIAL OF DTIC, CCNU, BLEOMYCIN, AND VINCRISTINE (BOLD) CHEMOTHERAPY FOR METASTATIC MELANOMA. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 24(MAR), 143–143.

REINTGEN, D. S., N. J. PICKETT, V. S. LUCAS, A. T. HUANG, and H. F. SEIGLER. “CLINICAL-TRIAL OF DTIC, CCNU, BLEOMYCIN, AND VINCRISTINE (BOLD) CHEMOTHERAPY FOR METASTATIC MELANOMA.” PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH 24, no. MAR (January 1, 1983): 143–143.

REINTGEN DS, PICKETT NJ, LUCAS VS, HUANG AT, SEIGLER HF. CLINICAL-TRIAL OF DTIC, CCNU, BLEOMYCIN, AND VINCRISTINE (BOLD) CHEMOTHERAPY FOR METASTATIC MELANOMA. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH. 1983 Jan 1;24(MAR):143–143.

REINTGEN, D. S., et al. “CLINICAL-TRIAL OF DTIC, CCNU, BLEOMYCIN, AND VINCRISTINE (BOLD) CHEMOTHERAPY FOR METASTATIC MELANOMA.” PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, vol. 24, no. MAR, AMER ASSOC CANCER RESEARCH, Jan. 1983, pp. 143–143.

REINTGEN DS, PICKETT NJ, LUCAS VS, HUANG AT, SEIGLER HF. CLINICAL-TRIAL OF DTIC, CCNU, BLEOMYCIN, AND VINCRISTINE (BOLD) CHEMOTHERAPY FOR METASTATIC MELANOMA. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH. AMER ASSOC CANCER RESEARCH; 1983 Jan 1;24(MAR):143–143.